Top Markets
#1 Velas Velas +562.78%
#2 Polymath Polymath +529.94%
#3 Galxe Galxe +96.05%
#4 XION XION +63.34%
#5 Resolv wstUSR Resolv wstUSR +59.11%
#6 Nomina Nomina +45.78%
#7 Cofinex Cofinex +26.87%
#8 Swarms Swarms +16.74%
#9 Unibase Unibase +15.72%
#10 Cysic Cysic +14.51%
Coin of the day
Velas Velas
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Exscientia plc Exscientia plc

Exscientia plc

EXAI
Rangering i aksjer #99999
Exscientia plc, an artificial intelligence-driven pharmatech company, engages... Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Aksjekurs
$4.84
Markedsverdi
$633.18M
Endring (1 dag)
3.20%
Endring (1 år)
0.00%
Land
GB
Handel Exscientia plc (EXAI)

Kategori

Healthcare
Inntekter for Exscientia plc (EXAI)
Inntekter i Sep 2024 TTM: $-207.65M
Ifølge Exscientia plc sine nyeste økonomiske rapporter er selskapets nåværende resultat $-207.65M. I 2022 hadde selskapet et resultat på $-167.36M, en nedgang sammenlignet med resultatet i 2021, som var $-56.36M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Exscientia plc fra 2019 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-207.65M 0.64%
2023 $-206.34M 23.29%
2022 $-167.36M 196.95%
2021 $-56.36M 24.08%
2020 $-45.42M 224.78%
2019 $-13.99M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
$20.46B -9,951.57%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$4.64B -2,336.03%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
$5.23B -2,618.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
$2.14B -1,129.45%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -877.39%
AU